Other Species / Isoforms
  K8 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsIRVtQks
0 5
K8 (human) ______MsIRVtQks S2-p
K8 iso2 (human) STPASTMSIRVTQKS S30
K8 (mouse) ______MsIRVTQKs S2-p
K8 (rat) ______MsVRVTQKs S2-p
T6-p
__MsIRVtQksykVs
Upstream
0 2
Kinase, in vitro:
  • AurB (human)
K8 (human) __MsIRVtQksykVs T6-p
K8 iso2 (human) STMSIRVTQKSYKVS T34
K8 (mouse) __MsIRVTQKsYkMs T6
K8 (rat) __MsVRVTQKsYKMs T6
K8-ac
MsIRVtQksykVsts
0 1
K8 (human) MsIRVtQksykVsts K8-ac
K8 iso2 (human) MSIRVTQKSYKVSTS K36
K8 (mouse) MsIRVTQKsYkMsts K8
K8 (rat) MsVRVTQKsYKMsTS K8
K8-ub
MsIRVtQksykVsts
0 4
K8 (human) MsIRVtQksykVsts K8-ub
K8 iso2 (human) MSIRVTQKSYKVSTS K36
K8 (mouse) MsIRVTQKsYkMsts K8
K8 (rat) MsVRVTQKsYKMsTS K8
K8-m1
MsIRVtQksykVsts
0 1
K8 (human) MsIRVtQksykVsts K8-m1
K8 iso2 (human) MSIRVTQKSYKVSTS K36
K8 (mouse) MsIRVTQKsYkMsts K8
K8 (rat) MsVRVTQKsYKMsTS K8
S9-p
sIRVtQksykVstsG
Upstream
2 28
Treatment
  • ischemia
K8 (human) sIRVtQksykVstsG S9-p
K8 iso2 (human) SIRVTQKSYKVSTSG S37
K8 (mouse) sIRVTQKsYkMstsG S9-p
K8 (rat) sVRVTQKsYKMsTSG S9-p
Y10-p
IRVtQksykVstsGP
0 3
K8 (human) IRVtQksykVstsGP Y10-p
K8 iso2 (human) IRVTQKSYKVSTSGP Y38
K8 (mouse) IRVTQKsYkMstsGP Y10
K8 (rat) VRVTQKsYKMsTSGP Y10
K11-ac
RVtQksykVstsGPr
Upstream
Downstream
2 14
Effects on Biological Processes:
  • cytoskeletal reorganization
Treatment
  • butyrate
K8 (human) RVtQksykVstsGPr K11-ac
K8 iso2 (human) RVTQKSYKVSTSGPR K39
K8 (mouse) RVTQKsYKMstsGPr K11
K8 (rat) RVTQKsYKMsTSGPR K11
K11-ub
RVtQksykVstsGPr
0 8
K8 (human) RVtQksykVstsGPr K11-ub
K8 iso2 (human) RVTQKSYKVSTSGPR K39
K8 (mouse) RVTQKsYkMstsGPr K11-ub
K8 (rat) RVTQKsYKMsTSGPR K11
K11-sm
RVtQksykVstsGPr
0 1
K8 (human) RVtQksykVstsGPr K11-sm
K8 iso2 (human) RVTQKSYKVSTSGPR K39
K8 (mouse) RVTQKsYKMstsGPr K11
K8 (rat) RVTQKsYKMsTSGPR K11
K11-m1
RVtQksykVstsGPr
0 1
K8 (human) RVtQksykVstsGPr K11-m1
K8 iso2 (human) RVTQKSYKVSTSGPR K39
K8 (mouse) RVTQKsYKMstsGPr K11
K8 (rat) RVTQKsYKMsTSGPR K11
S13-p
tQksykVstsGPrAF
Upstream
1 11
Treatment
  • ischemia
K8 (human) tQksykVstsGPrAF S13-p
K8 iso2 (human) TQKSYKVSTSGPRAF S41
K8 (mouse) TQKsYkMstsGPrAF S13-p
K8 (rat) TQKsYKMsTSGPRAF S13-p
S13-gl
tQksykVstsGPrAF
0 1
K8 (human) tQksykVstsGPrAF S13-gl
K8 iso2 (human) TQKSYKVSTSGPRAF S41
K8 (mouse) TQKsYkMStsGPrAF S13
K8 (rat) TQKsYKMSTSGPRAF S13
T14-p
QksykVstsGPrAFs
0 2
K8 (human) QksykVstsGPrAFs T14-p
K8 iso2 (human) QKSYKVSTSGPRAFS T42
K8 (mouse) QKsYkMstsGPrAFs T14-p
K8 (rat) QKsYKMsTSGPRAFs T14
S15-p
ksykVstsGPrAFss
0 3
K8 (human) ksykVstsGPrAFss S15-p
K8 iso2 (human) KSYKVSTSGPRAFSS S43
K8 (mouse) KsYkMstsGPrAFss S15-p
K8 (rat) KsYKMsTSGPRAFss S15
S15-gl
ksykVstsGPrAFss
0 1
K8 (human) ksykVstsGPrAFss S15-gl
K8 iso2 (human) KSYKVSTSGPRAFSS S43
K8 (mouse) KsYkMstSGPrAFss S15
K8 (rat) KsYKMsTSGPRAFss S15
R18-m1
kVstsGPrAFssrsy
0 19
K8 (human) kVstsGPrAFssrsy R18-m1
K8 iso2 (human) KVSTSGPRAFSSRSY R46
K8 (mouse) kMstsGPrAFssRsF R18-m1
K8 (rat) KMsTSGPRAFssRsF R18
R18-m2
kVstsGPrAFssrsy
0 1
K8 (human) kVstsGPrAFssrsy R18-m2
K8 iso2 (human) KVSTSGPRAFSSRSY R46
K8 (mouse) kMstsGPRAFssRsF R18
K8 (rat) KMsTSGPRAFssRsF R18
S21-p
tsGPrAFssrsytsG
0 50
K8 (human) tsGPrAFssrsytsG S21-p
K8 iso2 (human) TSGPRAFSSRSYTSG S49
K8 (mouse) tsGPrAFssRsFtsG S21-p
K8 (rat) TSGPRAFssRsFtsG S21-p
S22-p
sGPrAFssrsytsGP
0 30
K8 (human) sGPrAFssrsytsGP S22-p
K8 iso2 (human) SGPRAFSSRSYTSGP S50
K8 (mouse) sGPrAFssRsFtsGP S22-p
K8 (rat) SGPRAFssRsFtsGP S22-p
R23-m1
GPrAFssrsytsGPG
0 19
K8 (human) GPrAFssrsytsGPG R23-m1
K8 iso2 (human) GPRAFSSRSYTSGPG R51
K8 (mouse) GPrAFssRsFtsGPG R23
K8 (rat) GPRAFssRsFtsGPG R23
S24-p
PrAFssrsytsGPGs
5 130
K8 (human) PrAFssrsytsGPGs S24-p
K8 iso2 (human) PRAFSSRSYTSGPGS S52
K8 (mouse) PrAFssRsFtsGPGA S24-p
K8 (rat) PRAFssRsFtsGPGA S24-p
Y25-p
rAFssrsytsGPGsr
Upstream
0 92
Treatment
  • HGF
K8 (human) rAFssrsytsGPGsr Y25-p
K8 iso2 (human) RAFSSRSYTSGPGSR Y53
K8 (mouse) rAFssRsFtsGPGAR F25
K8 (rat) RAFssRsFtsGPGAR F25
T26-p
AFssrsytsGPGsrI
Upstream
0 33
Treatment
  • HGF
K8 (human) AFssrsytsGPGsrI T26-p
K8 iso2 (human) AFSSRSYTSGPGSRI T54
K8 (mouse) AFssRsFtsGPGARI T26-p
K8 (rat) AFssRsFtsGPGARI T26-p
S27-p
FssrsytsGPGsrIs
0 34
K8 (human) FssrsytsGPGsrIs S27-p
K8 iso2 (human) FSSRSYTSGPGSRIS S55
K8 (mouse) FssRsFtsGPGARIs S27-p
K8 (rat) FssRsFtsGPGARIs S27-p
S31-p
sytsGPGsrIssssF
0 19
K8 (human) sytsGPGsrIssssF S31-p
K8 iso2 (human) SYTSGPGSRISSSSF S59
K8 (mouse) sFtsGPGARIssssF A31
K8 (rat) sFtsGPGARIsSSsF A31
R32-m1
ytsGPGsrIssssFs
0 23
K8 (human) ytsGPGsrIssssFs R32-m1
K8 iso2 (human) YTSGPGSRISSSSFS R60
K8 (mouse) FtsGPGARIssssFs R32
K8 (rat) FtsGPGARIsSSsFs R32
S34-p
sGPGsrIssssFsrV
Upstream
1 57
Regulatory protein:
  • OGT (human)
Treatment
  • ischemia
K8 (human) sGPGsrIssssFsrV S34-p
K8 iso2 (human) SGPGSRISSSSFSRV S62
K8 (mouse) sGPGARIssssFsRV S34-p
K8 (rat) sGPGARIsSSsFsRV S34-p
S35-p
GPGsrIssssFsrVG
0 107
K8 (human) GPGsrIssssFsrVG S35-p
K8 iso2 (human) GPGSRISSSSFSRVG S63
K8 (mouse) GPGARIssssFsRVG S35-p
K8 (rat) GPGARIsSSsFsRVG S35
S36-p
PGsrIssssFsrVGs
0 14
K8 (human) PGsrIssssFsrVGs S36-p
K8 iso2 (human) PGSRISSSSFSRVGS S64
K8 (mouse) PGARIssssFsRVGs S36-p
K8 (rat) PGARIsSSsFsRVGs S36
S37-p
GsrIssssFsrVGss
Upstream
1 35
Treatment
  • metastatic potential
K8 (human) GsrIssssFsrVGss S37-p
K8 iso2 (human) GSRISSSSFSRVGSS S65
K8 (mouse) GARIssssFsRVGss S37-p
K8 (rat) GARIsSSsFsRVGss S37-p
S39-p
rIssssFsrVGssNF
0 42
K8 (human) rIssssFsrVGssNF S39-p
K8 iso2 (human) RISSSSFSRVGSSNF S67
K8 (mouse) RIssssFsRVGssss S39-p
K8 (rat) RIsSSsFsRVGssss S39-p
R40-m1
IssssFsrVGssNFr
0 14
K8 (human) IssssFsrVGssNFr R40-m1
K8 iso2 (human) ISSSSFSRVGSSNFR R68
K8 (mouse) IssssFsRVGsssss R40
K8 (rat) IsSSsFsRVGsssss R40
S43-p
ssFsrVGssNFrGGL
Upstream
1 82
Treatment
  • EGF
  • ischemia
K8 (human) ssFsrVGssNFrGGL S43-p
K8 iso2 (human) SSFSRVGSSNFRGGL S71
K8 (mouse) ssFsRVGsssssFRG S43-p
K8 (rat) SsFsRVGsssssFRG S43-p
S44-p
sFsrVGssNFrGGLG
0 24
K8 (human) sFsrVGssNFrGGLG S44-p
K8 iso2 (human) SFSRVGSSNFRGGLG S72
K8 (mouse) sFsRVGsssssFRGS S44-p
K8 (rat) sFsRVGsssssFRGs S44-p
N45
FsrVGssNFrGGLGG
0 2
K8 (human) FsrVGssNFrGGLGG N45
K8 iso2 (human) FSRVGSSNFRGGLGG N73
K8 (mouse) FsRVGsssssFRGSM S45-p
K8 (rat) FsRVGsssssFRGsL S45-p
-
gap
0 5
K8 (human) gap -
K8 iso2 (human) gap -
K8 (mouse) sRVGsssssFRGSMG S46-p
K8 (rat) sRVGsssssFRGsLG S46-p
-
gap
1 7
K8 (human) gap -
K8 iso2 (human) gap -
K8 (mouse) RVGsssssFRGSMGT S47-p
K8 (rat) RVGsssssFRGsLGG S47-p
R47-m1
rVGssNFrGGLGGGy
0 26
K8 (human) rVGssNFrGGLGGGy R47-m1
K8 iso2 (human) RVGSSNFRGGLGGGY R75
K8 (mouse) GsssssFRGSMGTGV R49
K8 (rat) GsssssFRGsLGGFG R49
R47-m2
rVGssNFrGGLGGGy
0 4
K8 (human) rVGssNFrGGLGGGy R47-m2
K8 iso2 (human) RVGSSNFRGGLGGGY R75
K8 (mouse) GsssssFRGSMGTGV R49
K8 (rat) GsssssFRGsLGGFG R49
G49
GssNFrGGLGGGyGG
1 2
K8 (human) GssNFrGGLGGGyGG G49
K8 iso2 (human) GSSNFRGGLGGGYGG G77
K8 (mouse) ssssFRGSMGTGVGL S51
K8 (rat) ssssFRGsLGGFGGA S51-p
Y54-p
rGGLGGGyGGAsGMG
0 1
K8 (human) rGGLGGGyGGAsGMG Y54-p
K8 iso2 (human) RGGLGGGYGGASGMG Y82
K8 (mouse) TGVGLGGFGGAGVGG F61
K8 (rat) FRGsLGGFGGAGVGG F55
S58-p
GGGyGGAsGMGGItA
0 1
K8 (human) GGGyGGAsGMGGItA S58-p
K8 iso2 (human) GGGYGGASGMGGITA S86
K8 (mouse) gap -
K8 (rat) gap -
T64-p
AsGMGGItAVtVNQs
0 1
K8 (human) AsGMGGItAVtVNQs T64-p
K8 iso2 (human) ASGMGGITAVTVNQS T92
K8 (mouse) GAGVGGITAVTVNQS T70
K8 (rat) GAGVGGITAVTVNQS T64
T67-p
MGGItAVtVNQsLLs
Downstream
1 3
Effects on Biological Processes:
  • cytoskeletal reorganization
K8 (human) MGGItAVtVNQsLLs T67-p
K8 iso2 (human) MGGITAVTVNQSLLS T95
K8 (mouse) VGGITAVTVNQSLLs T73
K8 (rat) VGGITAVTVNQSLLN T67
S71-p
tAVtVNQsLLsPLVL
0 1
K8 (human) tAVtVNQsLLsPLVL S71-p
K8 iso2 (human) TAVTVNQSLLSPLVL S99
K8 (mouse) TAVTVNQSLLsPLkL S77
K8 (rat) TAVTVNQSLLNPLKL S71
S74-p
tVNQsLLsPLVLEVD
Upstream
Downstream
28 17
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein stabilization
  • ubiquitination
Effects on Biological Processes:
  • apoptosis, induced
  • carcinogenesis, induced
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, altered
  • cell motility, inhibited
  • cytoskeletal reorganization
Kinase, in vitro:
  • JNK1 (human)
  • P38A (human)
Putative in vivo kinases:
  • MEK1 (human)
  • MEK2 (human)
  • P38A (human)
  • PKCD (human)
Putative upstream phosphatases:
  • PPP2CA (human)
  • PTP4A3 (human)
Regulatory protein:
  • JNK1 (human)
Treatment
  • anisomycin
  • BIRB-0796
  • Bupleurum_scorzonerifolium_extract
  • DEN
  • DMNQ
  • EGF
  • etoposide
  • Fas
  • fluid_shear_stress
  • griseofulvin
  • heat_shock
  • high_cell_density
  • hypertonic_buffer
  • hypotonic_buffer
  • Leukamenin E
  • menadione
  • MMS
  • okadaic_acid
  • PD98059
  • PHA-781089
  • PRL-3_inhibitor
  • SB202190
  • SB203580
  • serum_starvation
  • U0126
  • UV
  • vanadate
  • virus infection
K8 (human) tVNQsLLsPLVLEVD S74-p
K8 iso2 (human) TVNQSLLSPLVLEVD S102
K8 (mouse) TVNQSLLsPLkLEVD S80-p
K8 (rat) TVNQSLLNPLKLEVD N74
V77
QsLLsPLVLEVDPNI
0 1
K8 (human) QsLLsPLVLEVDPNI V77
K8 iso2 (human) QSLLSPLVLEVDPNI V105
K8 (mouse) QSLLsPLkLEVDPNI K83-ub
K8 (rat) QSLLNPLKLEVDPNI K77
T89-p
PNIQAVRtQEkEQIk
0 1
K8 (human) PNIQAVRtQEkEQIk T89-p
K8 iso2 (human) PNIQAVRTQEKEQIK T117
K8 (mouse) PNIQAVRTQEkEQIK T95
K8 (rat) PNIQAVRTQEKEQIK T89
K92
QAVRtQEKEQIktLN
0 2
K8 (human) QAVRtQEKEQIktLN K92
K8 iso2 (human) QAVRTQEKEQIKTLN K120
K8 (mouse) QAVRTQEkEQIKSLN K98-ac
K8 (rat) QAVRTQEKEQIKTLN K92
K92-ub
QAVRtQEkEQIktLN
0 4
K8 (human) QAVRtQEkEQIktLN K92-ub
K8 iso2 (human) QAVRTQEKEQIKTLN K120
K8 (mouse) QAVRTQEKEQIKSLN K98
K8 (rat) QAVRTQEKEQIKTLN K92
K96-ub
tQEkEQIktLNNkFA
0 8
K8 (human) tQEkEQIktLNNkFA K96-ub
K8 iso2 (human) TQEKEQIKTLNNKFA K124
K8 (mouse) TQEkEQIKSLNNkFA K102
K8 (rat) TQEKEQIKTLNNkFA K96
T97-p
QEkEQIktLNNkFAs
0 3
K8 (human) QEkEQIktLNNkFAs T97-p
K8 iso2 (human) QEKEQIKTLNNKFAS T125
K8 (mouse) QEkEQIKSLNNkFAs S103
K8 (rat) QEKEQIKTLNNkFAs T97
K101-ac
QIktLNNkFAsFIDk
Upstream
Downstream
1 45
Effects on Biological Processes:
  • cytoskeletal reorganization
Treatment
  • butyrate
K8 (human) QIktLNNkFAsFIDk K101-ac
K8 iso2 (human) QIKTLNNKFASFIDK K129
K8 (mouse) QIKSLNNkFAsFIDk K107-ac
K8 (rat) QIKTLNNkFAsFIDk K101-ac
K101-ub
QIktLNNkFAsFIDk
0 11
K8 (human) QIktLNNkFAsFIDk K101-ub
K8 iso2 (human) QIKTLNNKFASFIDK K129
K8 (mouse) QIKSLNNkFAsFIDk K107-ub
K8 (rat) QIKTLNNKFAsFIDk K101
K101-sm
QIktLNNkFAsFIDk
0 3
K8 (human) QIktLNNkFAsFIDk K101-sm
K8 iso2 (human) QIKTLNNKFASFIDK K129
K8 (mouse) QIKSLNNKFAsFIDk K107
K8 (rat) QIKTLNNKFAsFIDk K101
K101
QIktLNNKFAsFIDk
0 1
K8 (human) QIktLNNKFAsFIDk K101
K8 iso2 (human) QIKTLNNKFASFIDK K129
K8 (mouse) QIKSLNNkFAsFIDk K107-sc
K8 (rat) QIKTLNNKFAsFIDk K101
S104-p
tLNNkFAsFIDkVRF
0 29
K8 (human) tLNNkFAsFIDkVRF S104-p
K8 iso2 (human) TLNNKFASFIDKVRF S132
K8 (mouse) SLNNkFAsFIDkVRF S110-p
K8 (rat) TLNNkFAsFIDkVRF S104-p
K108-ac
kFAsFIDkVRFLEQQ
0 8
K8 (human) kFAsFIDkVRFLEQQ K108-ac
K8 iso2 (human) KFASFIDKVRFLEQQ K136
K8 (mouse) kFAsFIDKVRFLEQQ K114
K8 (rat) kFAsFIDkVRFLEQQ K108-ac
K108-ub
kFAsFIDkVRFLEQQ
0 12
K8 (human) kFAsFIDkVRFLEQQ K108-ub
K8 iso2 (human) KFASFIDKVRFLEQQ K136
K8 (mouse) kFAsFIDkVRFLEQQ K114-ub
K8 (rat) kFAsFIDKVRFLEQQ K108
K117-ac
RFLEQQNkMLETkWs
0 6
K8 (human) RFLEQQNkMLETkWs K117-ac
K8 iso2 (human) RFLEQQNKMLETKWS K145
K8 (mouse) RFLEQQNKMLETkWs K123
K8 (rat) RFLEQQNkMLETkWS K117-ac
K117-ub
RFLEQQNkMLETkWs
0 11
K8 (human) RFLEQQNkMLETkWs K117-ub
K8 iso2 (human) RFLEQQNKMLETKWS K145
K8 (mouse) RFLEQQNkMLETkWs K123-ub
K8 (rat) RFLEQQNKMLETkWS K117
K122-ac
QNkMLETkWsLLQQQ
0 11
K8 (human) QNkMLETkWsLLQQQ K122-ac
K8 iso2 (human) QNKMLETKWSLLQQQ K150
K8 (mouse) QNkMLETkWsLLQQQ K128-ac
K8 (rat) QNkMLETkWSLLQQQ K122-ac
K122-ub
QNkMLETkWsLLQQQ
0 9
K8 (human) QNkMLETkWsLLQQQ K122-ub
K8 iso2 (human) QNKMLETKWSLLQQQ K150
K8 (mouse) QNkMLETkWsLLQQQ K128-ub
K8 (rat) QNkMLETKWSLLQQQ K122
K122-m1
QNkMLETkWsLLQQQ
0 1
K8 (human) QNkMLETkWsLLQQQ K122-m1
K8 iso2 (human) QNKMLETKWSLLQQQ K150
K8 (mouse) QNkMLETKWsLLQQQ K128
K8 (rat) QNkMLETKWSLLQQQ K122
S124-p
kMLETkWsLLQQQkt
0 4
K8 (human) kMLETkWsLLQQQkt S124-p
K8 iso2 (human) KMLETKWSLLQQQKT S152
K8 (mouse) kMLETkWsLLQQQkT S130-p
K8 (rat) kMLETkWSLLQQQKT S124
K130-ac
WsLLQQQktARsNMD
0 2
K8 (human) WsLLQQQktARsNMD K130-ac
K8 iso2 (human) WSLLQQQKTARSNMD K158
K8 (mouse) WsLLQQQKTSRSNMD K136
K8 (rat) WSLLQQQKTSRSNMD K130
K130-ub
WsLLQQQktARsNMD
0 12
K8 (human) WsLLQQQktARsNMD K130-ub
K8 iso2 (human) WSLLQQQKTARSNMD K158
K8 (mouse) WsLLQQQkTSRSNMD K136-ub
K8 (rat) WSLLQQQKTSRSNMD K130
K130-sm
WsLLQQQktARsNMD
0 1
K8 (human) WsLLQQQktARsNMD K130-sm
K8 iso2 (human) WSLLQQQKTARSNMD K158
K8 (mouse) WsLLQQQKTSRSNMD K136
K8 (rat) WSLLQQQKTSRSNMD K130
T131-p
sLLQQQktARsNMDN
Upstream
0 3
Treatment
  • ischemia
K8 (human) sLLQQQktARsNMDN T131-p
K8 iso2 (human) SLLQQQKTARSNMDN T159
K8 (mouse) sLLQQQkTSRSNMDN T137
K8 (rat) SLLQQQKTSRSNMDN T131
S134-p
QQQktARsNMDNMFE
0 1
K8 (human) QQQktARsNMDNMFE S134-p
K8 iso2 (human) QQQKTARSNMDNMFE S162
K8 (mouse) QQQkTSRSNMDNMFE S140
K8 (rat) QQQKTSRSNMDNMFE S134
S142-p
NMDNMFEsyINNLRR
0 7
K8 (human) NMDNMFEsyINNLRR S142-p
K8 iso2 (human) NMDNMFESYINNLRR S170
K8 (mouse) NMDNMFESYINNLRR S148
K8 (rat) NMDNMFESYINNLRR S142
Y143-p
MDNMFEsyINNLRRQ
0 9
K8 (human) MDNMFEsyINNLRRQ Y143-p
K8 iso2 (human) MDNMFESYINNLRRQ Y171
K8 (mouse) MDNMFESYINNLRRQ Y149
K8 (rat) MDNMFESYINNLRRQ Y143
K158-ub
LETLGQEkLkLEAEL
0 3
K8 (human) LETLGQEkLkLEAEL K158-ub
K8 iso2 (human) LETLGQEKLKLEAEL K186
K8 (mouse) LEALGQEkLKLEAEL K164-ub
K8 (rat) LEALGQEKLKLEVEL K158
K160-ub
TLGQEkLkLEAELGN
0 2
K8 (human) TLGQEkLkLEAELGN K160-ub
K8 iso2 (human) TLGQEKLKLEAELGN K188
K8 (mouse) ALGQEkLKLEAELGN K166
K8 (rat) ALGQEKLKLEVELGN K160
K176-ub
QGLVEDFkNKYEDEI
0 2
K8 (human) QGLVEDFkNKYEDEI K176-ub
K8 iso2 (human) QGLVEDFKNKYEDEI K204
K8 (mouse) QGLVEDFKNkYEDEI K182
K8 (rat) QGLVEDFKNkYEDEI K176
K178
LVEDFkNKYEDEINK
0 3
K8 (human) LVEDFkNKYEDEINK K178
K8 iso2 (human) LVEDFKNKYEDEINK K206
K8 (mouse) LVEDFKNkYEDEINK K184-ac
K8 (rat) LVEDFKNkYEDEINK K178-ac
T187-p
EDEINKRtEMENEFV
0 1
K8 (human) EDEINKRtEMENEFV T187-p
K8 iso2 (human) EDEINKRTEMENEFV T215
K8 (mouse) EDEINKRTEMENEFV T193
K8 (rat) EDEINKRTEMENEFV T187
K197-ub
ENEFVLIkkDVDEAy
0 3
K8 (human) ENEFVLIkkDVDEAy K197-ub
K8 iso2 (human) ENEFVLIKKDVDEAY K225
K8 (mouse) ENEFVLIkkDVDEAy K203-ub
K8 (rat) ENEFVLIKkDVDEAY K197
K197-sm
ENEFVLIkkDVDEAy
0 1
K8 (human) ENEFVLIkkDVDEAy K197-sm
K8 iso2 (human) ENEFVLIKKDVDEAY K225
K8 (mouse) ENEFVLIKkDVDEAy K203
K8 (rat) ENEFVLIKkDVDEAY K197
K198
NEFVLIkKDVDEAyM
0 1
K8 (human) NEFVLIkKDVDEAyM K198
K8 iso2 (human) NEFVLIKKDVDEAYM K226
K8 (mouse) NEFVLIkKDVDEAyM K204
K8 (rat) NEFVLIKkDVDEAYM K198-ac
K198-ub
NEFVLIkkDVDEAyM
0 2
K8 (human) NEFVLIkkDVDEAyM K198-ub
K8 iso2 (human) NEFVLIKKDVDEAYM K226
K8 (mouse) NEFVLIkkDVDEAyM K204-ub
K8 (rat) NEFVLIKKDVDEAYM K198
Y204-p
kkDVDEAyMNkVELE
1 121
K8 (human) kkDVDEAyMNkVELE Y204-p
K8 iso2 (human) KKDVDEAYMNKVELE Y232
K8 (mouse) kkDVDEAyMNkVELE Y210-p
K8 (rat) KkDVDEAYMNkVELE Y204
K207-ac
VDEAyMNkVELEsRL
Upstream
1 5
Treatment
  • vorinostat
K8 (human) VDEAyMNkVELEsRL K207-ac
K8 iso2 (human) VDEAYMNKVELESRL K235
K8 (mouse) VDEAyMNKVELEsRL K213
K8 (rat) VDEAYMNkVELESRL K207-ac
K207-ub
VDEAyMNkVELEsRL
0 3
K8 (human) VDEAyMNkVELEsRL K207-ub
K8 iso2 (human) VDEAYMNKVELESRL K235
K8 (mouse) VDEAyMNkVELEsRL K213-ub
K8 (rat) VDEAYMNKVELESRL K207
S212-p
MNkVELEsRLEGLtD
0 4
K8 (human) MNkVELEsRLEGLtD S212-p
K8 iso2 (human) MNKVELESRLEGLTD S240
K8 (mouse) MNkVELEsRLEGLTD S218-p
K8 (rat) MNkVELESRLEGLTD S212
T218-p
EsRLEGLtDEINFLR
0 2
K8 (human) EsRLEGLtDEINFLR T218-p
K8 iso2 (human) ESRLEGLTDEINFLR T246
K8 (mouse) EsRLEGLTDEINFLR T224
K8 (rat) ESRLEGLTDEINFLR T218
Y228-p
INFLRQLyEEEIREL
Upstream
0 2
Treatment
  • nocodazole
K8 (human) INFLRQLyEEEIREL Y228-p
K8 iso2 (human) INFLRQLYEEEIREL Y256
K8 (mouse) INFLRQIHEEEIREL H234
K8 (rat) INFLRQIHEEEIREL H228
S240-p
RELQSQIsDtSVVLs
0 1
K8 (human) RELQSQIsDtSVVLs S240-p
K8 iso2 (human) RELQSQISDTSVVLS S268
K8 (mouse) RELQSQISDTSVVLs S246
K8 (rat) RELQSQISDTSVVLS S240
T242-p
LQSQIsDtSVVLsMD
0 1
K8 (human) LQSQIsDtSVVLsMD T242-p
K8 iso2 (human) LQSQISDTSVVLSMD T270
K8 (mouse) LQSQISDTSVVLsMD T248
K8 (rat) LQSQISDTSVVLSMD T242
S247-p
sDtSVVLsMDNSRsL
0 5
K8 (human) sDtSVVLsMDNSRsL S247-p
K8 iso2 (human) SDTSVVLSMDNSRSL S275
K8 (mouse) SDTSVVLsMDNSRsL S253-p
K8 (rat) SDTSVVLSMDNSRsL S247
S253-p
LsMDNSRsLDMDsII
0 30
K8 (human) LsMDNSRsLDMDsII S253-p
K8 iso2 (human) LSMDNSRSLDMDSII S281
K8 (mouse) LsMDNSRsLDMDGII S259-p
K8 (rat) LSMDNSRsLDMDsII S253-p
S258-p
SRsLDMDsIIAEVkA
Upstream
0 22
Treatment
  • BI2536
K8 (human) SRsLDMDsIIAEVkA S258-p
K8 iso2 (human) SRSLDMDSIIAEVKA S286
K8 (mouse) SRsLDMDGIIAEVRA G264
K8 (rat) SRsLDMDsIIAEVRA S258-p
K264-ub
DsIIAEVkAQyEDIA
0 8
K8 (human) DsIIAEVkAQyEDIA K264-ub
K8 iso2 (human) DSIIAEVKAQYEDIA K292
K8 (mouse) DGIIAEVRAQyEDIA R270
K8 (rat) DsIIAEVRAQYEEIA R264
Y267-p
IAEVkAQyEDIANRs
Upstream
Downstream
1 459
Effects on Biological Processes:
  • cytoskeletal reorganization
Putative upstream phosphatases:
  • PTP1B (human)
Treatment
  • EGF
  • gefitinib
  • HGF
  • PTP1B_inhibitor
K8 (human) IAEVkAQyEDIANRs Y267-p
K8 iso2 (human) IAEVKAQYEDIANRS Y295
K8 (mouse) IAEVRAQyEDIANRs Y273-p
K8 (rat) IAEVRAQYEEIANRS Y267
S274-p
yEDIANRsRAEAEsM
Upstream
0 17
Treatment
  • BI2536
K8 (human) yEDIANRsRAEAEsM S274-p
K8 iso2 (human) YEDIANRSRAEAESM S302
K8 (mouse) yEDIANRsRAEAETM S280-p
K8 (rat) YEEIANRSRAEAETM S274
S280-p
RsRAEAEsMyQIkyE
0 11
K8 (human) RsRAEAEsMyQIkyE S280-p
K8 iso2 (human) RSRAEAESMYQIKYE S308
K8 (mouse) RsRAEAETMYQIKYE T286
K8 (rat) RSRAEAETMYQIkYE T280
Y282-p
RAEAEsMyQIkyEEL
0 111
K8 (human) RAEAEsMyQIkyEEL Y282-p
K8 iso2 (human) RAEAESMYQIKYEEL Y310